Scandion Oncology
Overcoming cancer drug resistance
Navbar
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
News & Press
Press releases
Investors
Share information
Financial calendar
Financial Reports
Annual reports
Interim reports
Presentations
Business development
Analyst Coverage
Prospectuses
Subscription warrants
Rights Issue 2024
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
General meetings
Skip to content
Event
Q3 report 2025
« All Events
This event has passed.
11 November, 2025
«
Q2 report 2025
Add to calendar
Google Calendar
iCalendar
Outlook 365
Outlook Live
Details
Date:
11 November, 2025
Event Category:
Financial Events
